[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"intensive-care-patients\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:intensive-care-patients":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,9,0,[8,48,74,106,139,160,182,206,234],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":28,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":47},"100601222","prosthetic-joint-infection--lessons-from-deceased-patients-in-critical-care-100601222",false,"NCT07107685","Prosthetic Joint Infection : Lessons From Deceased Patients in Critical Care.","Osteoarticular Sepsis In Intensive Care Units : a Retrospective Study About Deceased Patients.","OASIS²","Inclusion Criteria:\n\n* Patient aged 18 years or older.\n* Hospitalization in critical care (intensive care unit or continuing care unit) between 2018 and 2022, lasting at least 48 hours, with a prosthetic joint infection (hip, knee, or shoulder prosthesis infection) as the primary or associated diagnosis.\n* Deceased patient who had not refused data processing.\n\nExclusion Criteria:\n\n* Infection involving osteosynthesis material\n* Infection involving spinal instrumentation\n* Patient with multiple infected prostheses\n* Recurrence of prosthetic infection with the same microorganism as a previous episode\n* Patient under legal protection\n* Pregnant or breastfeeding patient\n* Patient deprived of liberty","ALL","18 Years",{"count":20,"type":21},150,"ESTIMATED","OBSERVATIONAL","This is an observational, retrospective, multicenter study based on the use of demographic, clinical and biological data from deceased patients admitted between 2018 and 2022 to critical care with a principal or associated diagnosis of joint prosthesis infection.\n\nData from this study will be combined with that from the OASIS study (APHP241174\u002F ID-RCB: 2024-A01769-38) concerning osteoarticular sepsis on prosthetic material in critical care of living patients.\n\nThe aim of this study is to improve our knowledge of the profile, care trajectories and outcomes of patients hospitalized in critical care in the context of osteoarticular material sepsis.\n\nThe results of the study could help identify at-risk populations and improve management strategies for patients with osteoarticular sepsis.",[25,26,27],"Osteoarticular Infections","Intensive Care Patients","Prosthetic Joint Infection",[29,30,31,32,33,34],"Osteoarticular sepsis","sepsis","osteoarticular prothetis","intensive care","critical care","prosthetic joint infection","RECRUITING","2026-05-29",{"date":38,"type":39},"2026-06-01","ACTUAL",{"date":41,"type":39},"2025-09-24",{"date":43,"type":21},"2026-09-24",{"name":45,"class":46},"Assistance Publique - Hôpitaux de Paris","OTHER",1,{"id":49,"slug":50,"hasResults":11,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":4,"eligibilityCriteria":54,"healthyVolunteers":55,"sex":17,"minAge":18,"maxAge":56,"enrollmentInfo":57,"targetDuration":4,"studyType":59,"phases":60,"briefSummary":62,"conditions":63,"keywords":4,"overallStatus":64,"whyStopped":4,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":47},"100632983","therapeutic-touch-on-sleep-comfort-and-physiological-parameters-in-intensive-care-patients-100632983","NCT07520773","Therapeutic Touch on Sleep, Comfort, and Physiological Parameters in Intensive Care Patients","The Effect of Therapeutic Touch on Sleep, Comfort, and Physiological Parameters in Intensive Care Patients: A Randomized, Placebo-Controlled Study","Inclusion Criteria:\n\n1. Adults aged 18 and over.\n2. Patients who can communicate verbally.\n3. Patients monitored in the intensive care unit for at least 3 days.\n4. Patients who can give informed consent.\n5. Hemodynamically stable patients.\n\nExclusion Criteria:\n\n1. Patients under deep sedation.\n2. Patients on mechanical ventilation.\n3. Patients with psychiatric problems.\n4. Patients with skin diseases or conditions such as open wounds, infections, or burns that would prevent therapeutic touch.\n5. Patients with excessive sedation or delirium due to sedative\u002Fanalgesic use.\n6. Patients experiencing sudden, life-threatening clinical changes during intensive care (e.g., sudden cardiac arrest or shock).",true,"80 Years",{"count":58,"type":21},90,"INTERVENTIONAL",[61],"NA","Intensive care units are critical clinical areas where patients in life-threatening conditions receive care under advanced technology and continuous monitoring. In this environment, patients' sleep patterns and comfort levels are frequently disrupted, which can negatively affect physiological stability and the recovery process. The aim of this thesis proposal is to examine the effects of therapeutic touch applied to intensive care patients on sleep quality, comfort level, and physiological parameters. The research is planned as a randomized experimental study with intervention, placebo, and control groups. The study will be conducted in the Coronary Intensive Care Unit of Fırat University Hospital between April 2026 and January 2027, and a total of 90 patients meeting the research criteria will be randomized into intervention (n=30), placebo (n=30), and control (n=30) groups. The research materials consist of the Patient Identification Form, VAS-Comfort Scale, Sleep Scale, and measurements of physiological parameters (heart rate, blood pressure, body temperature, respiratory rate, oxygen saturation). The intervention group will receive therapeutic touch, the placebo group will receive superficial contact, and the control group will receive routine care. The applications will be performed daily at 8:00 PM, and comfort scale and physiological parameters will be measured before and 30 minutes after the application. Sleep quality, as an outcome variable occurring throughout the night, will be assessed the following day using the Sleep Scale. This process will be repeated for 3 days. The obtained data will be analyzed using appropriate statistical methods. In addition to descriptive statistics, One-Way Analysis of Variance (ANOVA) will be used for intergroup comparisons, and Repeated Measures ANOVA will be used to evaluate changes over time. In case of a significant difference, Bonferroni corrected post-hoc tests will be applied. If parametric assumptions are not met, appropriate non-parametric tests will be preferred. The significance level will be accepted as p\\\u003C0.05. This study aims to contribute to the development of evidence-based practices in nursing care by revealing the effects of therapeutic touch on sleep quality, comfort level, and physiological parameters of intensive care patients.",[26],"NOT_YET_RECRUITING","2026-04-09",{"date":67,"type":39},"2026-04-14",{"date":69,"type":21},"2026-05-01",{"date":71,"type":21},"2026-09-01",{"name":73,"class":46},"Firat University",{"id":75,"slug":76,"hasResults":11,"nctId":77,"briefTitle":78,"officialTitle":79,"acronym":80,"eligibilityCriteria":81,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":82,"targetDuration":4,"studyType":59,"phases":84,"briefSummary":86,"conditions":87,"keywords":90,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":99,"completionDateStruct":101,"leadSponsor":103,"locationsCount":105},"100567423","phase-4-the-intensive-care-platform-trial-100567423","NCT06667999","The Intensive Care Platform Trial","The Intensive Care Platform Trial (INCEPT)","INCEPT","The general eligibility criteria below apply to INCEPT as a whole and thus to all domains. Domains may impose domain-specific eligibility criteria that restrict the population eligible for that domain further, but domains are not allowed to broaden the general eligibility criteria. Domain-specific eligibility criteria always apply to all arms in a domain.\n\nPLATFORM INCLUSION CRITERIA:\n\n* Adult patient (≥18 years old) acutely admitted to the ICU. This includes ICU admissions after emergency surgery, unplanned ICU admissions after elective surgery, and prolonged ICU admissions due to complications after elective surgery (i.e., admissions occurring or being prolonged due to an unexpected, worsened condition, but excluding planned ICU admissions after elective surgery without clinical deterioration).\n* Eligible for at least one active domain.\n\nPLATFORM EXCLUSION CRITERIA:\n\n* Informed consent following inclusion expected to be unobtainable (e.g., known previous objections to participation).\n* Patient is under coercive measures (e.g., ongoing involuntary hospital stay or under the jurisdiction of correctional authorities).\n\nPatients who have previously been included in INCEPT may only be included again during new ICU admissions but may only be randomised to domains in which they have not previously been randomised.\n\nDOMAIN-SPECIFIC ELIGIBLE CRITERIA:\n\nEach domain may have additional eligibility criteria. Refer to the study website for more information (www.incept.dk).",{"count":83,"type":21},10000,[85],"PHASE4","Among critically ill patients, many die, and many of the survivors and their family members struggle for years with reduced quality of life. Critically ill patients are treated in intensive care units (ICUs). Here, they receive life support, e.g., mechanical ventilation and advanced support of the circulation (heart and blood vessels) and kidneys. In addition, ICU patients receive many other treatments. It is, however, uncertain if all the treatments provide value for the patients. The desirable effects of many treatments are uncertain, and some may be wasteful or even harmful.\n\nClinical trials are necessary to validly assess the desirable and undesirable effects of different treatments. However, conventional clinical trials have limitations:\n\n* They typically only assess a single question related to a single comparison of treatments at a time.\n* They are often not very flexible, including with regards to the number of participants needed, and this increases the risk that a trial will end up as inconclusive.\n* There is no or limited re-use or sharing of infrastructure across trials, leading to duplicate work and resource use.\n* Trial participants do usually not benefit from the obtained knowledge before the trial concludes.\n* Involvement of patients, family members, and other stakeholders is typically limited, which may decrease the relevance of the questions addressed.\n\nWith the Intensive Care Platform Trial (INCEPT), we aim to tackle these challenges by establishing a flexible platform trial that continuously learns from the obtained results. The platform trial may run forever with simultaneous and continuous assessment of many treatments. INCEPT will continuously learn from the accrued data and use these to improve the treatment of both participating and future patients. With INCEPT, we are also building a framework for thorough and extensive involvement of key stakeholders, including patients and family members. INCEPT will improve the way clinical trials are done and increase the probabilities that treatments are improved. This will:\n\n* Directly improve outcomes for ICU patients.\n* Relieve a strained healthcare system by discarding inefficient or harmful treatments.\n* Ensure that new treatments are beneficial or cost-effective before implementation.\n* Lower the costs and burdens of assessing more treatments in the critically ill.",[26,88,89],"Intensive Care Unit Patients","Critical Illness",[91,92,93,94,95],"Platform trial","Intensive care","Intensive care unit","Critical illness","Clinical platform trial","2026-03-18",{"date":98,"type":39},"2026-03-19",{"date":100,"type":39},"2025-06-26",{"date":102,"type":21},"2035-12",{"name":104,"class":46},"Anders Perner",21,{"id":107,"slug":108,"hasResults":11,"nctId":109,"briefTitle":110,"officialTitle":111,"acronym":112,"eligibilityCriteria":113,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":114,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":116,"conditions":117,"keywords":122,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":131,"lastUpdatePostDateStruct":132,"startDateStruct":134,"completionDateStruct":136,"leadSponsor":138,"locationsCount":47},"100619480","immunorea---immunological-and-inflammatory-determinants-associated-with-the-prognosis-of-intensive-care-patients-100619480","NCT07345169","IMMUNOREA - Immunological and Inflammatory Determinants Associated With the Prognosis of Intensive Care Patients","Studies on the Immunological and Inflammatory Determinants Associated With the Prognosis of Patients Admitted to Intensive Care","IMMUNOREA","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Admission to ICU within 24 hours\n\nExclusion Criteria:\n\n* Moribund patient (ECOG=4)\n* Legal protection (guardianship\u002Fcuratorship)\n* Uninsured patients\n* Pre-existing immunosuppression (active\u002Frecent cancer, hematologic disease, autoimmune disease, organ transplant, HIV)\n* Pregnant or breastfeeding women\n* Participation in another interventional trial\n* Patients under AME",{"count":115,"type":21},540,"This is a prospective observational physiopathological study aimed at evaluating the immunological and inflammatory determinants associated with the prognosis of patients admitted to intensive care units (ICU). The study will establish multidimensional models predicting one-year survival and the occurrence of nosocomial infections.\n\nPatients admitted to ICU undergo routine biological sampling. In addition to these, minimal supplementary samples will be collected for immunological and inflammatory biomarker analysis at admission, day 1, day 4, day 8, ICU discharge or day 28, and at 12 months. Additional samples may be taken during clinically significant events (nosocomial infections, complications).",[89,26,118,119,120,121],"Critical Illness Requiring Intensive Care - Sepsis","Critical Illness Requiring Intensive Care - Acute Brain Injury","Critical Illness Requiring Intensive Care - Major Surgery","Critical Illness Requiring Intensive Care - Polytrauma",[123,94,92,124,125,126,127,128,129,130],"Sepsis","Immunology","Inflammation","Transcriptomics","scRNAseq","Flow cytometry","Nosocomial infections","Prognosis","2026-01-06",{"date":133,"type":39},"2026-01-15",{"date":135,"type":21},"2026-01",{"date":137,"type":21},"2031-02",{"name":45,"class":46},{"id":140,"slug":141,"hasResults":11,"nctId":142,"briefTitle":143,"officialTitle":143,"acronym":144,"eligibilityCriteria":145,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":146,"targetDuration":4,"studyType":59,"phases":148,"briefSummary":149,"conditions":150,"keywords":4,"overallStatus":64,"whyStopped":4,"lastUpdateSubmitDate":152,"lastUpdatePostDateStruct":153,"startDateStruct":155,"completionDateStruct":157,"leadSponsor":159,"locationsCount":4},"100608501","impact-of-real-time-mic-minimum-inhibitory-concentration-reporting-6-hours-on--lactam-prescription-in-cases-of-gram-negative-bacilli-bacteremia-in-icu-patients-in-real-life-settings-100608501","NCT07202377","Impact of Real-time MIC (Minimum Inhibitory Concentration) Reporting (\u003C6 Hours) on β-lactam Prescription in Cases of Gram-negative Bacilli Bacteremia in ICU Patients in Real-life Settings","CMIBActRéa","Inclusion Criteria:\n\n* Adult patients aged over 18 years\n* Patients with a positive blood culture for Gram-negative bacilli (Enterobacterales, Pseudomonas aeruginosa, Acinetobacter baumannii) with results reported on weekdays before 11:00 ante meridiem (AM)\n* Patients clinically suspected of infection\n* Treated with empirical antibiotic therapy including a β-lactam, among the standard list of antibiotics to be tested recommended by CASFM-EUCAST (European Committee on Antimicrobial Susceptibility Testing) for Enterobacterales\u002FPseudomonas and included in the Reveal Rapid AST System panel\n* Hospitalized in intensive care unit (ICU) for at least the next 24 hours\n* Written informed consent obtained from the patient or a relative for study participation (emergency consent)\n* Affiliated with the French social security system\n\nExclusion Criteria:\n\n* Patients receiving withdrawal or limitation of care\n* Patients with an expected survival prognosis of less than 72 hours\n* Patients with bloodstream infections caused by Gram-negative bacilli other than Acinetobacter baumannii, Citrobacter freundii, Citrobacter koseri, Enterobacter cloacae, Escherichia coli, Klebsiella aerogenes, Klebsiella oxytoca, Klebsiella pneumoniae, Proteus mirabilis, or Pseudomonas aeruginosa\n* Patients treated with antibiotic therapy not including a β-lactam\n* Polymicrobial bloodstream infections\n* Pregnant or breastfeeding women\n* Patients under legal protection (guardianship or conservatorship)\n* Participation in another interventional research study",{"count":147,"type":21},200,[61],"Evaluate the impact of rapid, real-time (4 to 6 h) MIC reporting compared with the standard method (=diffusion antibiotic susceptibility testing) (18 to 24 h) on β-lactam prescribing in terms of the choice of molecule by the resuscitating clinician in the event of real-life Gram-negative Bacilli GNB bacteremia in the ICU.",[151,26],"Gram-negative Bacteremia","2025-09-29",{"date":154,"type":39},"2025-10-01",{"date":156,"type":21},"2025-10",{"date":158,"type":21},"2026-11",{"name":45,"class":46},{"id":161,"slug":162,"hasResults":11,"nctId":163,"briefTitle":164,"officialTitle":165,"acronym":166,"eligibilityCriteria":167,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":168,"targetDuration":4,"studyType":59,"phases":170,"briefSummary":171,"conditions":172,"keywords":4,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":173,"lastUpdatePostDateStruct":174,"startDateStruct":176,"completionDateStruct":177,"leadSponsor":179,"locationsCount":181},"100525385","can-a-patient-in-intensive-care-be-visited-by-his-or-her-pet-100525385","NCT06121050","Can a Patient in Intensive Care be Visited by His or Her Pet?","Can a Patient in Intensive Care be Visited by His or Her Pet? Feasibility Study.","ACCOMPAGNE","Inclusion Criteria:\n\n* Conscious adult patients with a pet (dog\u002Fcat).\n* Patients with no or no longer hemodynamic or respiratory failure, or undergoing rehabilitation, after resolution of the acute phase or at the end of life.\n* Patients affiliated to or entitled under a social security scheme.\n* Patient who has given written informed consent to participate in the study.\n\nExclusion Criteria:\n\n* Non-stabilized acute situation (as assessed by the resuscitator).\n* Mechanical or amine ventilation or extrarenal purification.\n* Tracheostomy.\n* Immunosuppression.\n* Carriage of multi-resistant bacteria.\n* Behavioral or consciousness disorders.\n* Pregnancy.\n* Skin wounds, extensive burns exceeding 15% of body surface area, external fixator.\n* Guardianship or trusteeship.\n* Workload incompatible with the visit\n* Patient unable to speak French.",{"count":169,"type":21},30,[61],"Nearly half of all intensive care patients describe symptoms of anxiety and depression after a stay in the ICU, and one in five has genuine post-traumatic stress disorder.\n\nAs a result, improving patient experience has become a priority in the ICU, and particular attention is being paid to the need to recreate a familiar environment.\n\nAnimal-mediated interventions have been developed for a number of patients over many years. These strategies are widely used with elderly patients, and patients with cognitive or psychiatric disorders, for whom the literature shows benefits on anxiety, mood or objective signs of stress.\n\nIn the vast majority of experiments carried out to date, the animals (mainly dogs) were prepared and educated for contact with patients, and their handlers trained in this activity, rather like guide dogs. Visiting a care facility with a patient's own pet is rarely described. It may run up against obstacles related to the animal's behavior or infectious risks, but it is nevertheless authorized in many establishments.",[26],"2025-07-03",{"date":175,"type":39},"2025-07-09",{"date":173,"type":39},{"date":178,"type":21},"2029-06",{"name":180,"class":46},"Centre Hospitalier Universitaire de Saint Etienne",2,{"id":183,"slug":184,"hasResults":11,"nctId":185,"briefTitle":186,"officialTitle":187,"acronym":4,"eligibilityCriteria":188,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":56,"enrollmentInfo":189,"targetDuration":4,"studyType":59,"phases":191,"briefSummary":192,"conditions":193,"keywords":194,"overallStatus":64,"whyStopped":4,"lastUpdateSubmitDate":197,"lastUpdatePostDateStruct":198,"startDateStruct":200,"completionDateStruct":202,"leadSponsor":204,"locationsCount":4},"100588811","transcutaneous-diaphragm-stimulation-in-icu-patients-100588811","NCT06946251","Transcutaneous Diaphragm Stimulation in ICU Patients","Evaluation of Patients With Reduced and Preserved Ejection Fraction After Transcutaneous Diaphragm Stimulation","Inclusion Criteria:\n\n* Patients aged between 18 and 80 years\n* Patients expected to require mechanical ventilation for at least 72 hours\n\nExclusion Criteria:\n\n* Presence of known neuromuscular diseases that contraindicate the use of transcutaneous diaphragm stimulation\n* Phrenic nerve injury\n* History of abdominal or thoracic surgery that prevents the application of diaphragm stimulation",{"count":190,"type":21},76,[61],"The aim of this study is to compare the effects of transcutaneous electrical diaphragm stimulation (TEDS) on diaphragm thickness, duration of mechanical ventilation, length of ICU stay, and right\u002Fleft heart functions between patient groups with low and high ejection fraction (EF) levels.\n\nThis randomized controlled trial will record demographic data, diaphragm ultrasound measurements, and echocardiographic findings of patients who receive or do not receive TEDS for five consecutive days.\n\nParticipants will be divided into four groups according to their EF levels and whether or not they receive diaphragm stimulation:\n\nGroup 1: Patients with low EF who receive TEDS Group 2: Patients with high EF who receive TEDS Group 3: Patients with low EF who do not receive TEDS Group 4: Patients with high EF who do not receive TEDS\n\nDiaphragm thickness and echocardiographic assessments will be performed at baseline and at the end of the five-day TEDS intervention.\n\nTEDS Application Protocol\n\nIn the ICU, TEDS is administered by a physiotherapist once daily for 20 minutes, five days a week, as part of the routine treatment protocol. The stimulation is delivered using the LGT-231 model device from the LONGEST brand.\n\nA transcutaneous current with a frequency of 30-50 Hz and a pulse width of 300-400 microseconds is applied to the diaphragm. The stimulation intensity is increased until visible muscle contraction is achieved.\n\nElectrode placement involves:\n\nThe first pair of electrodes placed bilaterally between the 8th and 10th anterior intercostal spaces, lateral to the xiphoid process.\n\nThe second pair placed along the mid-axillary line of the thorax, also between the 8th and 10th intercostal spaces.",[26],[195,93,196],"Diaphragm Stimulation","Ejection Fraction","2025-04-18",{"date":199,"type":39},"2025-04-27",{"date":201,"type":21},"2025-05",{"date":203,"type":21},"2026-05",{"name":205,"class":46},"Karadeniz Technical University",{"id":207,"slug":208,"hasResults":11,"nctId":209,"briefTitle":210,"officialTitle":211,"acronym":4,"eligibilityCriteria":212,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":213,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":215,"conditions":216,"keywords":221,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":225,"lastUpdatePostDateStruct":226,"startDateStruct":228,"completionDateStruct":230,"leadSponsor":232,"locationsCount":47},"100575320","family-involvement-in-icu-100575320","NCT06770751","Family Involvement in ICU","Family Involvement in the Intensive Care Unit: a Prospective Cohort Study Exploring Its Effects on Sedation Dosages, Delirium, Ventilator-Free Days, and Length of Stay.","Inclusion Criteria:\n\n* Patients aged 18 and over.\n* Patients with at least one family member actively involved in the care process in the ICU.\n\nExclusion Criteria:\n\n* Patients with pre-existing cognitive impairment or dementia.\n* Patients with severe traumatic brain injury.\n* Patients with an expected mortality in the ICU of more than 80%.\n* Absence of family members for patients admitted to the ICU.",{"count":214,"type":21},122,"The aim of this prospective cohort study was to investigate the effect of the time spent with relatives of patients treated in a tertiary intensive care unit on patient outcomes.\n\nThe main question it aimed to answer was:\n\nDoes spending more time with relatives of patients in intensive care result in lower sedative agent requirements? Does spending more time with relatives of patients in intensive care result in less delirium, fewer ventilator days, and shorter ICU stays?",[26,217,218,219,220],"Relatives","Delirium in the Intensive Care Unit","Sedatives","Family",[222,223,224,219],"Intensive care patients","relatives","Delirium in the intensive care unit","2025-01-15",{"date":227,"type":39},"2025-01-17",{"date":229,"type":39},"2025-01-13",{"date":231,"type":21},"2025-08-15",{"name":233,"class":46},"Istanbul University - Cerrahpasa",{"id":235,"slug":236,"hasResults":11,"nctId":237,"briefTitle":238,"officialTitle":239,"acronym":4,"eligibilityCriteria":240,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":241,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":243,"conditions":244,"keywords":4,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":248,"lastUpdatePostDateStruct":249,"startDateStruct":251,"completionDateStruct":253,"leadSponsor":255,"locationsCount":47},"100555307","two-bedside-ultrasound-techniques-and-standard-methods-for-confirmation-of-endotracheal-tube-insertion-in-intensive-care-patients-100555307","NCT06510387","Two Bedside Ultrasound Techniques and Standard Methods for Confirmation of Endotracheal Tube Insertion in Intensive Care Patients","Comparison of Two Bedside Ultrasound Techniques and Standard Methods for Confirmation of Endotracheal Tube Insertion in Intensive Care Patients, A Cross-Sectional Observational Study","Inclusion Criteria:\n\n* Patients \\> 18 years old.\n* Both sex.\n* All patients requiring prophylactic airway management e.g (patient with Glasgow Coma Scale \\\u003C8) with endotracheal intubation in the intensive care unit.\n\nExclusion Criteria:\n\n* An abnormal airway anatomy.\n* Tracheal or endobronchial lesion.\n* Significant cervical trauma.\n* Cervical abnormality.\n* Neck swelling.\n* Patients who need cardiopulmonary resuscitation.",{"count":242,"type":21},70,"This cross-sectional observational study aims to predict the sensitivity and specificity of ultrasonography using suprasternal and subxiphoid methods to confirm the correct placement of endotracheal tubes compared to standard methods in intensive care patients.",[245,246,247,26],"Two Bedside","Ultrasound","Endotracheal Tube","2024-07-14",{"date":250,"type":39},"2024-07-19",{"date":252,"type":39},"2023-10-01",{"date":254,"type":21},"2024-09-01",{"name":256,"class":46},"Tanta University"]